OD

Zenni® Optical Announces 2023 Eye Care Access Scholarship Winners

Retrieved on: 
Thursday, January 11, 2024
Student, Learning, Patient, Bureau, NOSA, Health, ABOC, Pacific University, University, Language, Growth, Indiana University Bloomington, Central Minnesota, OD, Education, Nursing

NOVATO, Calif., Jan. 11, 2024 /PRNewswire/ -- Zenni Optical, the world's leading online eyewear retailer, has awarded five optometry students with its 2023 Eye Care Access Scholarship. The scholarship program advances Zenni's commitment to helping the world live better and see better by supporting the growth of the optometry profession in the U.S.

Key Points: 
  • NOVATO, Calif., Jan. 11, 2024 /PRNewswire/ -- Zenni Optical , the world's leading online eyewear retailer, has awarded five optometry students with its 2023 Eye Care Access Scholarship.
  • Now in its second year, the Zenni Eye Care Access Scholarship recognizes incoming students who want to provide eye care to communities in need everywhere.
  • Students awarded the Zenni Eye Care Access Scholarship for the academic year 2023/2024 are those currently enrolled in U.S. Optometry Schools.
  • For more information on the Zenni Eye Care Access Scholarship and general Zenni information, please visit zenni.com/impact.

Prevent Blindness Issues Call for Nominations for the 2024 Jenny Pomeroy Award for Excellence in Vision and Public Health, and Rising Visionary Award

Retrieved on: 
Thursday, January 4, 2024
Associate, Policy, Essay, OD, Caregiver, Student, Doctor of Philosophy, Ohio State University, Public, Visual impairment, NIH, Nursing, Patient, Public health, Curriculum, Psychology, OSU, Primary health care, Pharmaceutical industry

CHICAGO, Jan. 4, 2024 /PRNewswire-PRWeb/ -- Prevent Blindness, the nation's leading eye health and safety organization, is issuing the call for nominations for the "2024 Jenny Pomeroy Award for Excellence in Vision and Public Health," and the fifth annual "Rising Visionary Award." Both awards will be formally presented at the 13th Annual Prevent Blindness Focus on Eye Health Summit on July 10-11, 2024.

Key Points: 
  • Prevent Blindness to present national awards at the 13th Annual Prevent Blindness Focus on Eye Health Summit, July 10-11, 2024
    CHICAGO, Jan. 4, 2024 /PRNewswire-PRWeb/ -- Prevent Blindness , the nation's leading eye health and safety organization, is issuing the call for nominations for the " 2024 Jenny Pomeroy Award for Excellence in Vision and Public Health ," and the fifth annual " Rising Visionary Award ."
  • Both the Jenny Pomeroy Award for Excellence in Vision and Public Health, and the Rising Visionary Award, provide us the opportunity to recognize the tremendous efforts of those dedicated to improving our nation's vision and eye health- Jeff Todd, president and CEO of Prevent Blindness.
  • Submission requirements for the Jenny Pomeroy Award for Excellence in Vision and Public Health include:
    A 500-word (or less) description of why the nominee is deserving of this award.
  • For more information on the Prevent Blindness Jenny Pomeroy Award for Excellence in Vision and Public Health and past recipients, please visit https://preventblindness.org/jenny-pomeroy-award-for-excellence-in-visio... .

Claris Bio Emerges From Stealth With a New Investor and Prepares for Next Development Stage With Late-Stage Data Expected in 1H24

Retrieved on: 
Thursday, January 4, 2024
Janus, Commercialization, OD, Drug development, Completeness, CMO, Hepatocyte growth factor, Master of Science, Novo Holdings A/S, Ear, MD, Neurotrophic factors, Nerve, Mass, Burns (surname), Mouth ulcer, Perforation, Ulcer, Series, Scar, MPH, Patient, NK, Medical imaging

Claris, initially funded in 2020, is developing recombinant human variant hepatocyte growth factor, dHGF, to accelerate and improve the quality of corneal healing in patients with corneal eye disease.

Key Points: 
  • Claris, initially funded in 2020, is developing recombinant human variant hepatocyte growth factor, dHGF, to accelerate and improve the quality of corneal healing in patients with corneal eye disease.
  • Oremepermin-α is epitheliotropic, neurotrophic, anti-inflammatory, and anti-fibrotic, suggesting it could be an efficacious and safe option to treat many current unmet needs in diseases of the cornea.
  • Claris expects to complete enrollment in its late-stage multi-center, randomized, double-masked, vehicle-controlled, parallel-group study, with a data readout expected in 1H2024.
  • Additional indications of interest that are being actively pursued by Claris, supported by preclinical and clinical data, include limbal stem cell deficiency and pre-existing corneal scar.

Marshall B. Ketchum University Celebrates 2023 Health Care Education Achievements and Innovations

Retrieved on: 
Wednesday, December 20, 2023
Nursing, Education, Health, Other Health, General Health, Optical, University, Faculty, Pharmacy, OD, SPAS, Student, Female, Accreditation, ACOE, SCCO, Accreditation Council, Master of Education, American Academy, Clinic, Pharmacist, MBKU, Growth, Patient

Marshall B. Ketchum University (MBKU), an independent, private, non-profit, accredited educational institution in Fullerton, California is grateful for a transformative year and proudly reflects on unprecedented success and innovation in health care education.

Key Points: 
  • Marshall B. Ketchum University (MBKU), an independent, private, non-profit, accredited educational institution in Fullerton, California is grateful for a transformative year and proudly reflects on unprecedented success and innovation in health care education.
  • I look forward to another year of growth and success.”
    In 2023, MBKU continued to raise the bar in health care education, solidifying its position as a leader in the industry.
  • Experiences like these drive Ketchum Health’s commitment to health care, positioning it as a community hub continually expanding to deliver affordable and accessible care.
  • Ultimately, we look forward to the continued prosperity of our organization and the health care profession as a whole.”

Nordic Pharma Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Completes Acquisition of Visant Medical to Launch Novel Therapy for Dry Eye Disease in the United States

Retrieved on: 
Monday, December 18, 2023
Medical Devices, Health, Clinical Trials, Pharmaceutical, Optical, Biotechnology, DED, University of Pikeville, OD, FDA, Acquisition, Drainage, Optometry, Professional corporation, MD, University, Associate professor, P.C, Telecanthus, CPT, Patient, Hyaluronic acid, Pharmaceutical industry

Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic Group B.V. (Nordic Pharma), announced today the completion of its acquisition of Visant Medical, Inc. (Visant), a leader in medical technology innovation in Dry Eye Disease (DED).

Key Points: 
  • Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic Group B.V. (Nordic Pharma), announced today the completion of its acquisition of Visant Medical, Inc. (Visant), a leader in medical technology innovation in Dry Eye Disease (DED).
  • Nordic Pharma will launch and commercialize LACRIFILL in the U.S. and has been chosen because of its focus on Ophthalmology.
  • This acquisition will enhance Nordic Pharma’s impact on the global ophthalmology market starting with the U.S. launch of LACRIFILL, the patented therapy for DED.
  • “Visant is thrilled to be joining the Nordic Pharma group,” said Vartan Ghazarossian, Ph.D., Visant co-founder and CEO.

Weave’s Second Annual User Conference Sessions Now Available on Demand

Retrieved on: 
Tuesday, December 5, 2023
Data Management, Health, Technology, Practice Management, Health Technology, Software, General Health, Momentum, Transformation, Patient satisfaction, Roadmap, OD, NYSE, Customer service, Learning, Practice management, DVM, Practice, Communication, Magic, Conference, Recognition, MBA, MD, Patient, DMD, Management, Dentistry, DDS, Success, Sanity, Weave

Weave (NYSE: WEAV), a leading all-in-one experience platform for small and medium-sized healthcare practices, recently hosted its second annual Weave Connect Conference to help practices grow their business, improve patient experience, and optimize staff efficiency and effectiveness.

Key Points: 
  • Weave (NYSE: WEAV), a leading all-in-one experience platform for small and medium-sized healthcare practices, recently hosted its second annual Weave Connect Conference to help practices grow their business, improve patient experience, and optimize staff efficiency and effectiveness.
  • Weave Connect was held on October 11-12, 2023 and all content from the event is now available on demand .
  • This year’s event featured a variety of expert-led breakout sessions and workshops, where industry key opinion leaders discussed how practice owners and office managers can build more profitable practices, improve communication, lead better during change, streamline important patient touchpoints, enhance their business operations, and more.
  • To access all content from Weave Connect 2023, please visit https://www.getweave.com/connect/

Old Dominion Freight Line, Inc. Announces General Rate Increase

Retrieved on: 
Monday, November 13, 2023
Trucking, Transport, Logistics, Supply Chain Management, Old Dominion Freight Line, GRI, OD, ODFL

Old Dominion Freight Line, Inc. (Nasdaq: ODFL) today announced a general rate increase (GRI) of 4.9 percent applicable to rates established under the existing ODFL 559, 670, and 550 tariffs, effective December 4, 2023.

Key Points: 
  • Old Dominion Freight Line, Inc. (Nasdaq: ODFL) today announced a general rate increase (GRI) of 4.9 percent applicable to rates established under the existing ODFL 559, 670, and 550 tariffs, effective December 4, 2023.
  • Todd A. Polen, Old Dominion Freight Line’s Vice President – Pricing Services, commented, “In line with our economic forecast and expectations for the anticipated operating environment, OD is implementing a general rate increase to ensure the continued enhancement of our high-quality service network and systems.
  • While the GRI’s impact will vary based on individual shipment lanes and distances traveled, it aligns with our long-term yield management strategy.
  • The GRI also includes nominal increases in minimum charges for intrastate, interstate, and cross-border lanes.”
    For more information about Old Dominion Freight Line, visit www.odfl.com or call (800) 432-6335.

Greenhouse Gases in Oceans Are Altered by Climate Change Impact on Microbes - An Incheon National University Study

Retrieved on: 
Thursday, December 7, 2023
The Marine Pollution Bulletin, Carbon, Associate, OD, Research, Climate change, Greenhouse, Nitrous oxide, OW, Ecosystem, OA, Methane, DL, Oceanography, AND, CH4, Incheon National University, Seaweed, N2O

GWANGJU, South Korea, Dec. 7, 2023 /PRNewswire/ -- The ocean is a global life-support system, and climate change causes such as ocean warming, acidification, deoxygenation, and nitrogen-deposition alter the delicate microbial population in oceans. The marine microbial community plays an important role in the production of greenhouse gases like nitrous oxide and methane. Scientists at Incheon National University have explored the climate change impact on marine microbes. Their research helps raise awareness about climate change severity and the importance of ocean resources.

Key Points: 
  • The marine microbial community plays an important role in the production of greenhouse gases like nitrous oxide and methane.
  • Scientists at Incheon National University have explored the climate change impact on marine microbes.
  • Their research helps raise awareness about climate change severity and the importance of ocean resources.
  • "Climate change leads to marine environmental changes and this study can enhance our understanding of their impact on human life," Prof. Kim says.

ORCAM TECHNOLOGIES UNVEILS ORCAM READ 3 - FIRST AI-DRIVEN ALL-IN-ONE SOLUTION FOR PEOPLE WITH LOW VISION AND VISUAL IMPAIRMENTS

Retrieved on: 
Tuesday, November 14, 2023
Handwriting, Red herring, Wi-Fi, Paratriathlon, Note, DSM-IV codes, Invention, Patient, Learning, Internet, Candy, OrCam device, Barcode, Friends, Glasses, Speech, Doctor of Philosophy, Frustration, Family, Gesture, AI, Dyslexia, Education, Book, Mobile phone, OD

This groundbreaking, all-in-one solution was unveiled today by OrCam Technologies , a global leader in personal, AI-driven assistive tech innovations.

Key Points: 
  • This groundbreaking, all-in-one solution was unveiled today by OrCam Technologies , a global leader in personal, AI-driven assistive tech innovations.
  • OrCam Read 3 will change the way individuals with vision loss and reading difficulties interact with visual materials.
  • An estimated 253 million people globally experience low vision and visual impairments.
  • The OrCam Learn is designed for the education market to help children with learning disabilities like dyslexia learn how to read.

TechTAC® Highlights Tubing Anchor that Can Navigate Oil Well Casing Patches

Retrieved on: 
Tuesday, November 7, 2023
Corrosion, Anomaly, TAC, ID, PPF, OD, SALT, Rope

This custom-made anchor leverages innovative mechanics and the unique design of the Slimline® to navigate an oil well casing patch or similar anomaly while still being able to fully set below the patch or affected area.

Key Points: 
  • This custom-made anchor leverages innovative mechanics and the unique design of the Slimline® to navigate an oil well casing patch or similar anomaly while still being able to fully set below the patch or affected area.
  • “Oil well casings may need to be patched for a variety of reasons – from corrosion to mechanical damage – and those patches can create unique challenges for tubing anchors,” said Luke Reary, Operations Manager with TechTAC®.
  • However, this approach can limit the effectiveness of the anchor if the casing patch is placed high up within the well.
  • For example, a 5.5” 20 PPF patched casing has a reduced drift of 4.218” compared to 4.653” for an unpatched casing drift.